EIF4A2 and diffuse large B-cell lymphoma: Given that eIF4A inhibitors demonstrated a statistically significant reduction in cell proliferation in DLBCL subtypes as well as depletion of critical oncogenes, we next performed a colony formation assay with a panel of DLBCL and lymphoblastoid cells.